It is on the results of Bangla Desh that the Indian states of Uttar Pradesh and Assam had dropped hydroxychloroquine for this ivermectin doxycycline combination
For the record, another study which demonstrated the superiority of this dual therapy over that of Raoult
A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy is COVID19 patients.
In principle, this opens the way to the pursuit of randomized studies and all the hoopla
To be continued....
The article that relates it
The study
"A Case Series of 100 Covid-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline"
This observational study, consisting of 64 males and 36 females was conducted from April to May 2020 (Figure 2) at Bangladesh Medical College. The oldest patient was 84 years old and the youngest was 8 years old with most patients between 21 and 40 years old (Figure 3).
Patients were divided into 3 groups: mild (73), Moderate (20) and severe (7), depending on their symptoms.
Among the severe patients, three had more fever than 103 Fahrenheit for seven days with severe cough and pulmonary infiltrates, three had severe loose movements and one had uncontrolled diabetes.
Of the remainder, 20 patients presented with moderate symptoms of mild fever (100 Fahrenheit) and mild cough. In addition, 73 had
symptoms of malaise, sore throat, loss of smell, loss of taste and body aches. Fifty percent symptomatic improvement in mild to moderate patients was observed between the 3rd and 5th day after the start of treatment.
All 7 patients' severe symptoms improved by 50% on the 7th day of treatment. A new test was carried out between 4 and 18 days after the start of treatment (Figure 4).
Twenty-five patients underwent retesting between days 4 and 8, 51 on days 9-13, and 24 on days 14-18 after starting treatment.
All patients tested negative.
None required ICU admission and no deaths have been reported.